Publikationen
Hier finden Sie eine chronologische Auflistung der Veröffentlichungen der Forschungsgruppe.
Zeige Ergebnisse 1 bis 10 von 49.
Publikation
| 2025
Adenovirus E1B-55K interferes with cellular IκB kinase complex subunit proteins.
- Ip W-H, Bertzbach LD, Schreiner S, Dobner T
-
Front Immunol,
Publikation
| 2024
The protein composition of human adenovirus replication compartments.
- Hidalgo P, Torres A, Jean Beltran PM, López-Leal G, Bertzbach LD, Dobner T, Flint SJ, Cristea IM, González RA
-
mBio,
Publikation
| 2024
Functional characterization of OR51B5 and OR1G1 in human lung epithelial cells as potential drug targets for non-type 2 lung diseases.
- Awad N, Weidinger D, Greune L, Kronsbein J, Heinen N, Westhoven S, Pfaender S, Taube C, Reuter S, Peters M, Hatt H, Fender A, Knobloch J
-
Cell Biol Toxicol,
Publikation
| 2024
Divergent autoantibody and cytokine levels in COVID-19 sepsis patients influence survival.
- Kühn D, Heinen N, Sutter K, Herrmann ST, Nocke MK, Todt D, Burbelo PD, Steinmann E, Ziehe D, Koos B, Adamzik M, Putensen C, Zarbock A, Gravemann U, Jork C, Pfaender S
-
J Med Virol,
Publikation
| 2024
Cellular SUMO-specific proteases regulate HAdV-C5 E1B-55K SUMOylation and virus-induced cell transformation.
- Ip W-H, Fiedler M, Gornott B, Morische M, Bertzbach LD, Dobner T
-
Front Cell Infect Microbiol,
Publikation
| 2024
DiscovEpi: automated whole proteome MHC-I-epitope prediction and visualization.
- Mahncke C, Schmiedeke F, Simm S, Kaderali L, Bröker BM, Seifert U, Cammann C
-
BMC Bioinformatics,
Publikation
| 2024
Orally bioavailable RORγ/DHODH dual host-targeting small molecules with broad-spectrum antiviral activity.
- Herrmann A, Gege C, Wangen C, Wagner S, Kögler M, Cordsmeier A, Irrgang P, Ip W-H, Weil T, Hunszinger V, Groß R, Heinen N, Pfaender S, Reuter S, Klopfleisch R, Uhlig N, Eberlein V, Issmail L, Grunwald T, Hietel B, Cynis H, Münch J, Sparrer KMJ, Ensser A, Tenbusch M, Dobner T, Vitt D, Kohlhof H, Hahn F
-
Antiviral Res,
Publikation
| 2024
The triglyceride-synthesizing enzyme diacylglycerol acyltransferase 2 modulates the formation of the hepatitis C virus replication organelle.
- Reichert I, Lee JY, Weber L, Fuh MM, Schlaeger L, Rößler S, Kinast V, Schlienkamp S, Conradi J, Vondran FWR, Pfaender S, Scaturro P, Steinmann E, Bartenschlager R, Pietschmann T, Heeren J, Lauber C, Vieyres G
-
PLoS Pathog,
Publikation
| 2024
MicroRNAs modulate SARS-CoV-2 infection of primary human hepatocytes by regulating the entry factors ACE2 and TMPRSS2.
- Khanal R, Heinen N, Bogomolova A, Meister TL, Herrmann ST, Westhoven S, Nocke MK, Todt D, Jockenhövel F, Klein IM, Hartmann L, Vondran FWR, Steinmann E, Zimmer G, Ott M, Brown RJP, Sharma AD, Pfaender S
-
Liver Int,
Publikation
| 2024
Telomeric repeats in the commercial SB-1 vaccine facilitate viral integration and contribute to vaccine efficacy.
- You Y, Kheimar AM, Vychodil T, Kossak L, Sabsabi MA, Conradie AM, Reddy SM, Bertzbach LD, Kaufer BB
-
NPJ Vaccines,
